141 related articles for article (PubMed ID: 32833714)
1. High-Dose Dabigatran Is an Effective Anticoagulant for Simulated Cardiopulmonary Bypass Using Human Blood.
Nadtochiy SM; Baldzizhar A; Stefanos T; Feng C; O'Leary KE; Jones-Smith KL; Angona RE; Eaton MP
Anesth Analg; 2021 Feb; 132(2):566-574. PubMed ID: 32833714
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban Reduces the Dabigatran Dose Required for Anticoagulation During Simulated Cardiopulmonary Bypass.
Nadtochiy SM; Stefanos T; Angona RE; Lebedko N; Baldzizhar A; Feng C; Eaton MP
Anesth Analg; 2022 Jul; 135(1):52-59. PubMed ID: 35389372
[TBL] [Abstract][Full Text] [Related]
3. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography.
Solbeck S; Meyer MA; Johansson PI; Meyer AS; Cotton BA; Stensballe J; Schött U; Ostrowski SR
Int J Cardiol; 2014 Oct; 176(3):794-9. PubMed ID: 25156858
[TBL] [Abstract][Full Text] [Related]
5. Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
Glund S; Stangier J; van Ryn J; Schmohl M; Moschetti V; Haazen W; De Smet M; Gansser D; Norris S; Lang B; Reilly P; Kreuzer J
Clin Pharmacokinet; 2017 Jan; 56(1):41-54. PubMed ID: 27317414
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Dabigatran Provides Adequate Anticoagulation for Cardiopulmonary Bypass Using a Rabbit Model.
Nadtochiy SM; Stefanos T; Angona RE; Darrow N; Jones CCPK; Feng C; Algahim M; LeMoine D; Westcott R; Anderson B; Swartz MF; Eaton MP
Anesthesiology; 2023 May; 138(5):523-532. PubMed ID: 36821759
[TBL] [Abstract][Full Text] [Related]
7. In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma: comparisons using thromboelastography and microscopic visualization of fibrin clot structure.
Nossair FF; Chan HHW; Gantioqui J; Atkinson HM; Berry LR; Chan AKC
Blood Coagul Fibrinolysis; 2017 Oct; 28(7):551-557. PubMed ID: 28505011
[TBL] [Abstract][Full Text] [Related]
8. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
Dietrich W
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
[TBL] [Abstract][Full Text] [Related]
9. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
[TBL] [Abstract][Full Text] [Related]
10. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
Taune V; Skeppholm M; Ågren A; Gryfelt G; Malmström RE; Wikman A; Van Ryn J; Wallén H
J Thromb Haemost; 2018 Dec; 16(12):2462-2470. PubMed ID: 30288934
[TBL] [Abstract][Full Text] [Related]
11. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
12. The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation.
Božič Mijovski M; Malmström RE; Vene N; Antovic JP; Mavri A
Sci Rep; 2021 Mar; 11(1):5920. PubMed ID: 33723299
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
McKellar SH; Abel S; Camp CL; Suri RM; Ereth MH; Schaff HV
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1410-6. PubMed ID: 21429525
[TBL] [Abstract][Full Text] [Related]
14. The effect of dabigatran on the kaolin-activated whole blood thromboelastogram.
'Aho A; Byrne K
Anaesth Intensive Care; 2016 Nov; 44(6):729-733. PubMed ID: 27832560
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Glund S; Stangier J; Schmohl M; Gansser D; Norris S; van Ryn J; Lang B; Ramael S; Moschetti V; Gruenenfelder F; Reilly P; Kreuzer J
Lancet; 2015 Aug; 386(9994):680-90. PubMed ID: 26088268
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide releasing molecule-2 improves coagulation in patient plasma in vitro following cardiopulmonary bypass.
Malayaman SN; Entwistle JW; Boateng P; Wechsler AS; Persaud JM; Cohen JB; Kirklin JK; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):362-8. PubMed ID: 21346555
[TBL] [Abstract][Full Text] [Related]
17. Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran.
Takeshita S; Tanaka KA; Sawa T; Sanda M; Mizobe T; Ogawa S
Anesth Analg; 2020 Feb; 130(2):535-541. PubMed ID: 31490820
[TBL] [Abstract][Full Text] [Related]
18. Incomplete dabigatran reversal with idarucizumab.
Steele AP; Lee JA; Dager WE
Clin Toxicol (Phila); 2018 Mar; 56(3):216-218. PubMed ID: 28704111
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
20. Idarucizumab, but not procoagulant concentrates, fully restores dabigatran-altered platelet and fibrin components of hemostasis.
Arellano-Rodrigo E; Fernandez-Gallego V; López-Vilchez I; Molina P; Díaz-Ricart M; Zafar MU; Badimon JJ; van Ryn J; Escolar G
Transfusion; 2019 Jul; 59(7):2436-2445. PubMed ID: 30946491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
